For most companies in the pharmaceutical industry, converting a batch API process into continuous process is likely to go beyond being a technical challenge to the development chemists and engineers. Supporting groups in regulatory, EHS and Quality roles will also be impacted. In this session we want to identify and explore the big challenges facing the development of continuous processes and the conversion of batch to continuous processes.
03:15 PM
03:25 PM
Chenchi Wang, Thomas Laporte
03:45 PM
04:05 PM
James Ciszewski, Michael Gonzalez
04:25 PM
Brian G. Lefebvre, Caitlin A. Boyd, Sonia M. Berberena, Laura Kuczynski, Pamela L. Kubinski, Megerle L. Scherholz, Dr. Stephanie Farrell, Robert Hesketh, Michael J. Girgis
04:45 PM
Pedro Sá Gomes, Michal Zabka, Viviana Silva, Alírio E. Rodrigues
05:05 PM
Hiroshi Machida, Wataru Endo, Ryosuke Taguchi, Masaru Watanabe, Yoshiyuki Sato, Richard L. Smith
05:25 PM
Patricia M. Portillo, Aditya U. Vanarase, M.G. Ierapetritou, Fernando J. Muzzio